Market Intel: Peripheral Nerve Stim Players Edge Out Innovative Paths

While demand for spinal cord stimulation (SCS) devices used in pain management continues to expand at double-digit rates, a small but growing number of highly innovative companies that develop stimulators to specifically target peripheral nerve pain is creating excitement among pain doctors looking for better options to treat an intractable population that's seen little success with standard therapy. With millions of people worldwide suffering from low back pain, severe headaches and migraines, neck pain and other chronic pain, the demand for safe, effective, percutaneously-placed devices remains high. In this article, we'll highlight emerging companies working on PNS devices and provide insights from pain physicians on the pros and cons of these devices.

Nrervous System

Chronic pain afflicts more than one billion people worldwide and there are over 100 deaths caused by opioid overdose in the US alone, creating the need for safer and more effective pain therapy, according to the Centers for Disease Control and Prevention.

Advancements in neurostimulation or "pain neuromodulation", using implantable spinal cord stimulation (SCS) devices as well as emerging peripheral nerve stimulators, are seen as viable non-addictive alternatives to treat everything

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Neurology

More from Device Area